XML 57 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Cash Flows (Unaudited) (USD $)
9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Cash Flows From Operating Activities:    
Net loss $ (1,341,771) $ (1,085,588)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization expense 562,130 503,016
Gain on sale of asset (5,450) 0
Accretion of asset retirement obligation (3,600) 6,030
Common stock issued to directors for services 0 2,628
Common stock issued for services 39,000 0
Deferred income tax expense 0 229,451
Change in:    
Accounts receivable, net (409,525) (207,261)
Inventories (98,145) 312,584
Other current assets (19,729) (33,118)
Other assets (55,139) (165,438)
Accounts payable 140,261 348,121
Due to factor 148,571 157,482
Accrued payroll, taxes and interest (14,877) 10,835
Other accrued liabilities (14,755) 44,695
Deferred revenue (68,623) 91,692
Payables to related parties 13,059 (8,988)
Net cash provided by operating activities (1,128,593) 206,141
Cash Flows From Investing Activities:    
Purchase of properties, plants and equipment (1,315,846) (1,742,783)
Net cash used by investing activities (1,315,846) (1,742,783)
Cash Flows From Financing Activities:    
Proceeds from issuance of long term debt 130,000 200,000
Net proceeds from sale of common stock and exercise of warrants 3,070,134 653,604
Principal payments on notes payable to bank (138,520) 0
Principal payments on long-term debt (99,344) (232,931)
Net cash provided by financing activities 2,962,270 620,673
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS 517,831 (915,969)
Cash and cash equivalents at beginning of period 20,343 1,000,811
Cash and cash equivalents at end of period 538,174 84,842
Noncash investing and financing activities:    
Properties, plants & equipment acquired with long-term debt 19,040 0
Properties, plants and equipment acquired with accounts payable 0 318,335
Common stock issued for debt payment 330,000 0
Fair value of derivative liability 0 108,750
Equipment sold for note receivable 10,000 0
Common stock issued for notes receivable $ 150,000 $ 0